22nd Century Group (22nd Century Group) ROCE % : 1,879.29% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is 22nd Century Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. 22nd Century Group's annualized ROCE % for the quarter that ended in Dec. 2023 was 1,879.29%.

22nd Century Group ROCE % Historical Data

The historical data trend for 22nd Century Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

22nd Century Group ROCE % Chart

22nd Century Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-39.18

-36.46

-58.17

-43.13

-86.98

22nd Century Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-2.16	-68.02	-74.54	-459.58	1,879.29

22nd Century Group ROCE % Calculation

22nd Century Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-45.273	/	( ( (114.651 - 13.018)	+	(27.503 - 25.034) )	/ 2 )
	=	-45.273	/	( (101.633	+	2.469)	/ 2 )
	=	-45.273	/	52.051
	=	-86.98 %

22nd Century Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	252.812	/	( ( (64.196 - 39.76)	+	(27.503 - 25.034) )	/ 2 )
	=	252.812	/	( ( 24.436	+	2.469 )	/ 2 )
	=	252.812	/	13.4525
	=	1,879.29 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

22nd Century Group (NAS:XXII) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

22nd Century Group ROCE % Related Terms

Thank you for viewing the detailed overview of 22nd Century Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

22nd Century Group (22nd Century Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » 22nd Century Group Inc (NAS:XXII) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Seneca Street, Suite 507, Buffalo, NY, USA, 14204

Website

https://www.xxiicentury.com

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has two operating segments; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain 95% less nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM, and The hemp/cannabis segment is engaged in providing hemp-derived cannabinoid ingredients and API, as well as a CDMO to the consumer goods industry. It derives a majority of its revenue from the tobacco segment.

Executives

Andrew Arno	director	C/O MERRIMAN CURHAN FORD GROUP, INC., 600 CALIFORNIA STREET, 9TH FLOOR, SAN FRANCISCO CA 94108
James A Mish	director, officer: Chief Executive Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
John Franzino	officer: Chief Administrative Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Peter Ferola	officer: Chief Legal Officer	BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
John J Miller	officer: President, Tobacco	500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Lucille S Salhany	director	C/O HEWLETT-PACKARD CO, 3000 HANOVER STREET, PALO ALTO CA 94304
Michael Zercher	officer: Chief Operating Officer	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Robert Hugh Kinsman	officer: Chief Financial Officer	500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Clifford B Fleet	director	6601 WEST BROAD STREET, RICHMOND VA 23230
Richard F Fitzgerald	officer: Chief Financial Officer	C/O TECHPRECISION CORPORATION, ONE BELLA DRIVE, WESTMINSTER MA 01473
Anthony L. Johnson	director	C/O 22ND CENTURY GROUP, INC., 500 SENECA STREET, SUITE 507, BUFFALO NY 14204
Richard M. Sanders	director	1119 PIEDRA RONDO, SANTA FE NM 87501
Roger D O'brien	director	C/O 22ND CENTURY GROUP, INC., 8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Michael Koganov	director	8560 MAIN STREET, SUITE 4, WILLIAMSVILLE NY 14221
Nora B Sullivan	director	C/O RAND CAPITAL CORP, 2200 RAND BLDG, BUFFALO NY 14203